Effect of platelet-rich plasma on the regeneration of damaged tissues (review)
https://doi.org/10.17238/2072-3180-2025-4-171-178
Abstract
Introduction. Platelet-rich plasma (PRP) is a universal stimulator of damaged tissue regeneration, promotes healing of damaged tissue, has anti-inflammatory, bactericidal and bacteriostatic effects, not only at the tissue level, but also at the cellular level.
Main part. Platelet-rich plasma can be used in clinical practice as an alternative to antibacterial drugs (mainly beta-lactams) and hormonal drugs, which in turn can lead to significant side effects. An important advantage of using platelet-rich plasma is the fact that it does not have an oncogenic effect. With a combination of platelet-rich plasma and mesenchymal stem cells, additional stimulation of regeneration occurs, while mesenchymal stem cells adapt their secretome to the environment and their paracrine action can last for several days after transplantation. PRP is a safe stimulator of damaged tissue regeneration, an anti-inflammatory treatment. PRP is used in many areas of medicine: cosmetology, dermatology, surgery, dentistry, gynecology.
Conclusion. The use of platelet-rich plasma is relevant wherever stimulation of damaged tissue regeneration and anti-inflammatory therapy are required. Also, PRP has proven itself in preclinical studies on laboratory animals.
About the Authors
V. A. GusevaRussian Federation
Guseva Veronika Andreevna – Candidate of Veterinary Sciences, Veterinarian
199226, Saint Petersburg, Korablostroiteley str., 16, building 3
R. R. Akhmerov
Germany
Akhmerov Renat Rashitovich – MD, Professor, General Director of the Laboratory
10789, Germany, Berlin, Rankestraße 26
T. R. Akhmerov
Russian Federation
Akhmerov Timur Renatovich – student at the Faculty of Medicine
117198, Moscow, 6 Miklukho-Maklaya str.,
References
1. Akhmerov R.R., Korotkova O.I., Ovechkin M.V. et al. The use of platelet-containing autoplasm in dermatocosmetology and dentistry. PLASMOLIFTING™ technology. Plastic Surgery and Cosmetology, 2013, № 1, рp. 94–104. [In Russ.]
2. Marx R.E., Carlson E.R., Eichstaedt R.M., Schimmele S.R., Strauss J.E., Georgeff K.R. Platelet-rich plasma: Growth factor enhancement for bone grafts. Oral Surg. Oral Med. Oral Pathol., 1998, vol. 85, рр. 638–646. https://doi: 10.1016/S1079-2104(98)90029-4
3. Akhmerov R.R., Zarudiy R.F., Korotkova O.I. and others. Plasmolifting technology is an injectable form of platelet autoplasm for the treatment of chronic catarrhal gingivitis. Periodontology, 2012, № 4(65) pр. 80–84. [In Russ.]
4. Akhmerov R.R., Ovechkina M.V., Tsyplakov D.E. et al. PlasmoliftingTM technology is an injectable form of platelet autoplasm for the treatment of chronic periodontitis of I–II severity. Periodontology, 2013, № 1, pр. 45–54. [In Russ.]
5. Zakharov A.Yu., Bokarev A.V., Stekolnikov A., Blusma A.O., Narusbaeva M.A. Optimization of the method for obtaining platelet-rich plasma (PRP) from horse blood. Issues of regulatory regulation in veterinary medicine, 2020, № 4, pр. 89. [In Russ.]
6. Trippel S.B. Growth factors as therapeutic agents. Instr. Course Lect., 1997, vol. 46, pp. 473–476.
7. Lopez-Vidriero E., Goulding K.A., Simon D.A. et all. The use of platelet-rich plasma in arthroscopy and sports medicine: optimizing the healing environment. Arthroscopy, 2010, № 26, рр. 269278.
8. Stellos K., Kopf S., Paul A. et all. Platelets in regeneration. Semin Thromb Hemost, 2010, № 36, pp 175-184.
9. Vishnyakova P., Artemova D., Elchaninov A. Effects of platelet-rich plasma on mesenchymal stem cells isolated from rat uterus. https://www.researchgate.net/publication/346728058_Effects_of_platelet-rich_plasma_on_mesenchymal_stem_cells_isolated_from_rat_uterus.
10. Hersant B., Sid-Ahmed M., Braud L., Jourdan M., Baba-Amer Y., Meningaud J-P., Rodriguez A-M. Platelet-Rich Plasma Improves the Wound Healing Potential of Mesenchymal Stem Cells through Paracrine and Metabolism Alterations. https://onlinelibrary.wiley.com/doi/10.1155/2019/1234263.
11. Xie I., Wang I., Zhao C., Guo S., Liu S., Jia W., Tuan R. S. and Zhang C., Comparative evaluation of MSCs from bone marrow and adipose tissue placed in a PRP framework for cartilage regeneration. Biomaterials, 2012, № 33, № 29, рр. 7008–7018. [In Russ.] https://doi.org/10.1016/j.biomaterials.2012.06.058
12. Foster T.E., Puskas B.L., Mandelbaum B.R. et all. Platelet-rich plasma: from basic science to clinical applications. Am J Sports Med, 2009, № 37, pp. 2259–2272.
13. Sanchez M., Anitua E., Azofra J. et all. Intraarticular injection of an autologous preparation rich in growth factors for the treatment of knee OA: a retrospective cohort study. Clin Exp Rheumatol, 2008, № 26, pp. 910–913.
14. Floryan K., Berghoff W.J. Intraoperative use of autologous platelet rich and platelet poor plasma for orthopedic surgery patients. AORN J, 2004, № 80, рр. 668–674.
15. Akhmerov R.R. Regenerative medicine based on the use of autologous blood plasma. Plasmolifting technology. M. : Litterra, 2020. 208 p. [In Russ.]
16. Samodai V.G., Brekhov V.L., Gaidukov V.E., Rylkov M.I., Fedorishchev A.P. The use of platelet-rich autoplasm in the surgical treatment of bone tissue defects with impaired bone continuity. Systems Analysis and Management in Biomedical Systems, 2007, № 6(2), pp. 493–495. [In Russ.]
17. Markou N., Pepelassi E., Vavouraki H., Stamatakis H.C., Nikolopoulos G., Vrotsos I., Tsiklakis K. Treatment of periodontal endosseous defects with platelet-rich plasma alone or in combination with demineralized freeze-dried bone allograft: a comparative clinical trial. J Periodontol., 2009, № 80(12), pp. 1911–1919.
18. Sell S.A., Wolfe P.S., Ericksen J.J., Simpson D.G., Bowlin G.L. Incorporating platelet-rich plasma into electrospun scaffolds for tissue engineering applications. Tissue Eng. Part A., 2011, № 17(21–22), pp. 2723–2737.
19. Nakamura Y., Tensho K., Nakaya H., Nawata M., Okabe T., Wakitani S. Low dose fibroblast growth factor-2 (FGF-2) enhances bone morphogenetic protein-2 (BMP-2)-induced ectopic bone formation in mice. Bone., 2005, № 36(3), pp 399–407.
20. Fortier L.A., Barker J.U., Strauss E.J., McCarrel T.M., Cole B.J. The role of growth factors in cartilage repair. Clin Orthop Relat Res., 2011, № 469(10), pp. 2706–2715.
21. Kim H.K., Song K.S., Chung J.H., Lee K.R., Lee S.N. Platelet microparticles induce angiogenesis in vitro. Br J Haematol., 2004, № 124(3), pp. 376–384.
22. Nguyen RT, Borg-Stein J, McInnis K. Applications of platelet-rich plasma in musculoskeletal and sports medicine: an evidence-based approach. PM R., 2011, № 3(3), pp. 226–250.
23. Klimovitsky V.G., Solovyov I.A. The use of platelet-rich plasma in the treatment of soft and bone tissue injuries (Literature review). Trauma, 2015. [In Russ.]
24. Kalashnikov P.I., Samodai V.G. Experimental use of platelet-derived growth factors in bone osteosynthesis. Young Scientist, 2014, № 17, pр. 158–161. [In Russ.]
25. Pertungaro P.S. The use of platelet-rich plasma with growth factors (autogenic platelet gel) to improve the healing of hard and soft tissues during bone build-up in the area of the pneumatized sinus. An electronic resource. [In Russ.]
26. Chekalina E.N. The role of platelet concentrate in tissue repair and regeneration. An electronic resource. [In Russ.]
27. Adda F. Promoting scarring in steam implantology. Platelets with a high fibrin content. An electronic resource. [In Russ.]
28. Lopez-Vidriero E., Goulding K.A., Simon D.A., Sanchez M., Johnson D.H. The use of platelet-rich plasma in arthroscopy and sports medicine: optimizing the healing environment. Arthroscopy, 2010, № 26 (2), pp. 269–278.
29. Li J.J., Huang Y.Q., Basch R., Karpatkin S. Thrombin induces the release of angiopoietin-1 from platelets. tromb. Haemost., 2001, № 85 (2), pp. 204–206.
30. O’Reilly M. S., Boehm T., Shing Y., Fukai N., Vasios G., Lane W. S., Flynn E., Birkhead J. R., Olsen B. R., Folkman J. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell, 1997, № 88 (2), pp. 277–285.
Review
For citations:
Guseva V.A., Akhmerov R.R., Akhmerov T.R. Effect of platelet-rich plasma on the regeneration of damaged tissues (review). Moscow Surgical Journal. 2025;(4):171-178. (In Russ.) https://doi.org/10.17238/2072-3180-2025-4-171-178

















